Literature DB >> 26372

Circulatory and alpha-adrenoceptor blocking effects of phentolamine.

D A Richards, E P Woodings, B N Prichard.   

Abstract

1 Intravenously administered phentolamine provoked immediate decreases in diastolic blood pressure but increases in heart rate and cardiac output. 2 These immediate circulatory effects had largely disappeared twenty minutes after administration and at this time phentolamine did not inhibit increases in blood pressure which were provoked during hand immersion in ice-cold water. 3 Log dose-response curves of noradrenaline induced increases in systolic and diastolic pressure 20 min after intravenous phentolamine were shifted to the right in a parallel manner compared with the curves before phentolamine administration. 4 It was concluded that the immediate and short acting effects induced by phentolamine are due to a non-specific vasodilator effect but in addition phentolamine causes a longer acting alpha-adrenoceptor blockade at vascular adrenoceptor sites. However, by producing both pre- and post-synaptic alpha-adrenoceptor blockade this may explain why this drug exerts only a weak antihypertensive effect.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 26372      PMCID: PMC1429377          DOI: 10.1111/j.1365-2125.1978.tb01665.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.

Authors:  D A Richards; J Tuckman; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

2.  A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS.

Authors:  G A ROSE; W W HOLLAND; E A CROWLEY
Journal:  Lancet       Date:  1964-02-08       Impact factor: 79.321

3.  THE CIRCULATORY EFFECTS OF PHENTOLAMINE IN MAN WITH PARTICULAR RESPECT TO CHANGES IN FOREARM BLOOD FLOW.

Authors:  S H TAYLOR; G R SUTHERLAND; G J MACKENZIE; H P STAUNTON; K W DONALD
Journal:  Clin Sci       Date:  1965-04       Impact factor: 6.124

4.  THE CIRCULATORY EFFECTS OF INTRAVENOUS PHENTOLAMINE IN MAN.

Authors:  S H TAYLOR; G R SUTHERLAND; G J MACKENZIE; H P STAUNTON; K W DONALD
Journal:  Circulation       Date:  1965-05       Impact factor: 29.690

5.  The clinical results of oral and parenteral administration of 2-(N'p-tolyl-N'-m-hydroxyphenylaminomethyl) imidazoline hydrochloride (regitine) in the treatment of hypertension and an evaluation of the cerebral hemodynamic effects.

Authors:  J H MOYER; C CAPLOVITZ
Journal:  Am Heart J       Date:  1953-04       Impact factor: 4.749

6.  STUDIES ON PAIN. OBSERVATIONS ON PAIN DUE TO LOCAL COOLING AND ON FACTORS INVOLVED IN THE "COLD PRESSOR" EFFECT.

Authors:  S Wolf; J D Hardy
Journal:  J Clin Invest       Date:  1941-09       Impact factor: 14.808

7.  Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.

Authors:  P A Majid; M K Meeran; M E Benaim; B Sharma; S H Taylor
Journal:  Br Heart J       Date:  1974-06

8.  Hemodynamic and catecholamine changes during a standard cold pressor test.

Authors:  R P Cuddy; H Smulyan; J F Keighley; C R Markason; R H Eich
Journal:  Am Heart J       Date:  1966-04       Impact factor: 4.749

9.  Effects of adrenergic blockade on the pulmonary circulation in man.

Authors:  S H Taylor; G J Mackenzie; M George; A McDonald
Journal:  Br Heart J       Date:  1965-09

10.  The effects of labetalol (AH 5158) on adrenergic transmission in the cat spleen.

Authors:  A G Blakeley; R J Summers
Journal:  Br J Pharmacol       Date:  1977-04       Impact factor: 8.739

View more
  11 in total

1.  Circulatory effects of noradrenaline and adrenaline before and after labetalol.

Authors:  D A Richards; B N Prichard; R Hernández
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

2.  Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension.

Authors:  L Sampieri; C Cuspidi; L Boselli; L Angioni; G Castiglioni; A Zanchetti; G Mancia
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

Review 3.  Vasodilators in acute circulatory failure.

Authors:  C Blakeley; J Tinker
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

Review 4.  Clinical pharmacology of labetalol.

Authors:  D A Richards; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

5.  Cardiovascular effects of indoramin in man--a dose ranging study.

Authors:  D P Nicholls; D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

6.  The pressor actions of noradrenaline, angiotensin II and saralasin in chronic autonomic failure treated with fludrocortisone.

Authors:  B Davies; R Bannester; P Sever; C Wilcox
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

7.  A review of the haemodynamic effects of labetalol in man.

Authors:  J N Cohn; J Mehta; G S Francis
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 8.  Pharmacology of combined alpha-beta-blockade. I.

Authors:  W J Louis; J J McNeil; O H Drummer
Journal:  Drugs       Date:  1984       Impact factor: 9.546

9.  Clonidine-induced suppression of plasma catecholamines in states of adrenal medulla hyperfunction.

Authors:  M D Gross; B Shapiro; J C Sisson; A Zweifler
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

10.  Alpha- and beta- adrenergic receptors regulate inflammatory responses to acute and chronic sleep fragmentation in mice.

Authors:  Nicholas D Wheeler; David C Ensminger; Megan M Rowe; Zachary S Wriedt; Noah T Ashley
Journal:  PeerJ       Date:  2021-06-24       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.